Clinical Trials

Showing trials with last updates posted in 2025.

NCT05715463 | ACTIVE_NOT_RECRUITING | NA
101 participants

Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-15
Start Date:
2023-03-01
Completion:
2025-10-14
Conditions
  • Rheumatoid Arthritis
  • Palindromic Arthritis
  • Juvenile Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Sacroiliitis
  • Psoriatic Arthritis
  • Mixed Connective Tissue Disease
  • Lupus
  • Enteropathic Arthropathies
  • Systemic Sclerosis
  • Sjogren's Syndrome
  • Sicca Syndrome
  • Inflammatory Arthritis
  • Undifferentiated Connective Tissue Diseases
Interventions
  • OTHER
No Results Yet
NCT05105841 | COMPLETED | PHASE2
20 participants

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-15
Start Date:
2021-11-08
Completion:
2025-10-09
Conditions
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
Interventions
  • DRUG
No Results Yet
NCT04678336 | TERMINATED | PHASE1
12 participants

CD123 Redirected T Cells for AML in Pediatric Subjects

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-15
Start Date:
2021-04-02
Completion:
2025-05-09
Conditions
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia, Pediatric
  • Acute Myeloid Leukemia, Refractory
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page